Related Experiment Video

Updated: May 8, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Stents or surgery in coronary artery disease in 2013

David P Taggart1

  • 1Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Annals of Cardiothoracic Surgery
|August 27, 2013
PubMed

Insights

For coronary artery disease, recent trials show coronary artery bypass grafting (CABG) is superior to stenting in certain patients. A multidisciplinary team approach is recommended for intervention decisions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Optimal medical therapy is standard for coronary artery disease (CAD).
  • Some CAD patients require revascularization for symptom relief or improved prognosis.
  • The choice between coronary artery bypass grafting (CABG) and stenting remains a key clinical question.

Purpose of the Study:

  • To compare the long-term efficacy of CABG versus stenting in patients with CAD.
  • To evaluate the impact of recent trial data on current revascularization practices.
  • To emphasize the importance of a multidisciplinary team in guiding intervention strategies.

Main Methods:

  • Analysis of five-year outcomes from major clinical trials (SYNTAX and FREEDOM).
  • Inclusion of data from large patient registries.
  • Review of current interventional practices and guidelines.

Main Results:

  • Five-year data from SYNTAX and FREEDOM trials indicate CABG offers better outcomes in specific patient groups.
  • Registries support the trial findings regarding the relative effectiveness of CABG and stenting.
  • Evidence suggests inappropriate stenting in patients who would benefit more from CABG.

Conclusions:

  • CABG is the preferred revascularization strategy for certain complex coronary artery disease patients.
  • Current practices may lead to suboptimal treatment selection.
  • Intervention recommendations for CAD should be managed by a multidisciplinary heart team.

Keywords:
Coronary artery bypass graftingFREEDOMSYNTAXheart teamstents

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...